Table of Content
1 CAR T-Cell Therapy Market Introduction and Overview
1.1 CAR T-Cell Therapy Introduction
1.2 Research Purposes
1.3 Report Timeline
1.4 Market Size Analysis by Types
1.5 Market Size Analysis by Applications
1.6 Market Size Analysis by Regions
2 Global Market Growth Trends Analysis
2.1 Global CAR T-Cell Therapy Market Size & Forecast (2017-2028)
2.2 CAR T-Cell Therapy Growth Trends Analysis by Regions
2.2.1 CAR T-Cell Therapy Market Size by Regions: 2017 VS 2021 VS 2027
2.2.2 CAR T-Cell Therapy Historic Market Share by Regions (2017-2022)
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Regions (2023-2028)
3 Global CAR T-Cell Therapy Historical and Forecast Market Analysis by Type
3.1 Global CAR T-Cell Therapy Revenue and Market Share by Type
3.2 Global CAR T-Cell Therapy Market Forecast by Type (2023-2028)
4 Global CAR T-Cell Therapy Historical and Forecast Market Analysis by Applications
4.1 Global CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
4.2 CAR T-Cell Therapy Market Forecast by Application (2023-2028)
5 North America CAR T-Cell Therapy Market analysis
5.1 North America CAR T-Cell Therapy Revenue by Type (2017-2028)
5.2 North America CAR T-Cell Therapy Revenue by Application (2017-2028)
5.3 North America CAR T-Cell Therapy Revenue and Market Share by Countries
5.3.1 North America CAR T-Cell Therapy Revenue by Country (2017-2028)
5.3.2 United States CAR T-Cell Therapy Revenue and Growth (2017-2028)
5.3.3 Canada CAR T-Cell Therapy Revenue and Growth (2017-2028)
5.3.5 Mexico CAR T-Cell Therapy Revenue and Growth (2017-2028)
6 Europe CAR T-Cell Therapy Market analysis
6.1 Europe CAR T-Cell Therapy Revenue by Type (2017-2028)
6.2 Europe CAR T-Cell Therapy Revenue by Application (2017-2028)
6.3 Europe CAR T-Cell Therapy Revenue and Market Share by Countries
6.3.1 Europe CAR T-Cell Therapy Revenue by Country (2017-2028)
6.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.3 France CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7 Asia-Pacific CAR T-Cell Therapy Market analysis
7.1 Asia-Pacific CAR T-Cell Therapy Revenue by Type (2017-2028)
7.2 Asia-Pacific CAR T-Cell Therapy Revenue by Application (2017-2028)
7.3 Asia-Pacific CAR T-Cell Therapy Revenue and Market Share by Countries
7.3.1 Asia-Pacific CAR T-Cell Therapy Revenue by Country (2017-2028)
7.3.2 China CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.5 India CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
8 Latin America CAR T-Cell Therapy Market analysis
8.1 Latin America CAR T-Cell Therapy Revenue by Type (2017-2028)
8.2 Latin America CAR T-Cell Therapy Revenue by Application (2017-2028)
8.3 Latin America CAR T-Cell Therapy Revenue and Market Share by Countries
8.3.1 Latin America CAR T-Cell Therapy Revenue by Country (2017-2028)
8.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2017-2028)
8.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2017-2028)
9 Middle East & Africa CAR T-Cell Therapy Market analysis
9.1 Middle East & Africa CAR T-Cell Therapy Revenue by Type (2017-2028)
9.2 Middle East & Africa CAR T-Cell Therapy Revenue by Application (2017-2028)
9.3 Middle East & Africa CAR T-Cell Therapy Revenue and Market Share by Countries
9.3.1 Middle East & Africa CAR T-Cell Therapy Revenue by Country (2017-2028)
9.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2017-2028)
9.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
9.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2017-2028)
10 CAR T-Cell Therapy Industry Dynamic Analysis
10.1 CAR T-Cell Therapy Market Trends Analysis
10.2 CAR T-Cell Therapy Market Drivers Analysis
10.3 CAR T-Cell Therapy Market Challenges Analysis
10.4 CAR T-Cell Therapy Market Restraints Analysis
10.5 CAR T-Cell Therapy Industry Mergers & Acquisitions
10.6 CAR T-Cell Therapy Industry New Entrants and Expansion Plans
11 Key Players Analysis
11.1 Global CAR T-Cell Therapy Revenue and Market Share Analysis by Key Players
11.2 Global CAR T-Cell Therapy Market Concentration Rate Analysis
11.2.1 Top 3 CAR T-Cell Therapy Key Players Market Share
11.2.2 Top 6 CAR T-Cell Therapy Key Players Market Share

11.3 Novartis
11.3.1 Business Overview
11.3.2 CAR T-Cell Therapy Major Business
11.3.3 Novartis Product and Service Introduction
11.3.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.3.5 Recent Developments and Future Plans
11.4 Gilead Sciences
11.4.1 Business Overview
11.4.2 CAR T-Cell Therapy Major Business
11.4.3 Gilead Sciences Product and Service Introduction
11.4.4 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.4.5 Recent Developments and Future Plans
11.5 Bristol-Myers Squibb
11.5.1 Business Overview
11.5.2 CAR T-Cell Therapy Major Business
11.5.3 Bristol-Myers Squibb Product and Service Introduction
11.5.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.5.5 Recent Developments and Future Plans
11.6 J & J
11.6.1 Business Overview
11.6.2 CAR T-Cell Therapy Major Business
11.6.3 J & J Product and Service Introduction
11.6.4 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.6.5 Recent Developments and Future Plans
11.7 JW Therapeutics
11.7.1 Business Overview
11.7.2 CAR T-Cell Therapy Major Business
11.7.3 JW Therapeutics Product and Service Introduction
11.7.4 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.7.5 Recent Developments and Future Plans
11.8 FOSUNKite
11.8.1 Business Overview
11.8.2 CAR T-Cell Therapy Major Business
11.8.3 FOSUNKite Product and Service Introduction
11.8.4 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.8.5 Recent Developments and Future Plans
11.9 CARsgen Therapeutics (Pipeline)
11.9.1 Business Overview
11.9.2 CAR T-Cell Therapy Major Business
11.9.3 CARsgen Therapeutics (Pipeline) Product and Service Introduction
11.9.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.9.5 Recent Developments and Future Plans
11.10 Autolus Therapeutics(Pipeline)
11.10.1 Business Overview
11.10.2 CAR T-Cell Therapy Major Business
11.10.3 Autolus Therapeutics(Pipeline) Product and Service Introduction
11.10.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.10.5 Recent Developments and Future Plans
11.11 Sorrento Therapeutics(Pipeline)
11.11.1 Business Overview
11.11.2 CAR T-Cell Therapy Major Business
11.11.3 Sorrento Therapeutics(Pipeline) Product and Service Introduction
11.11.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.11.5 Recent Developments and Future Plans
11.12 Mustang Bio(Pipeline)
11.12.1 Business Overview
11.12.2 CAR T-Cell Therapy Major Business
11.12.3 Mustang Bio(Pipeline) Product and Service Introduction
11.12.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.12.5 Recent Developments and Future Plans
11.13 Bluebird Bio(Pipeline)
11.13.1 Business Overview
11.13.2 CAR T-Cell Therapy Major Business
11.13.3 Bluebird Bio(Pipeline) Product and Service Introduction
11.13.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.13.5 Recent Developments and Future Plans
11.14 Cellectis(Pipeline)
11.14.1 Business Overview
11.14.2 CAR T-Cell Therapy Major Business
11.14.3 Cellectis(Pipeline) Product and Service Introduction
11.14.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.14.5 Recent Developments and Future Plans
11.15 Allogene Therapeutics(Pipeline)
11.15.1 Business Overview
11.15.2 CAR T-Cell Therapy Major Business
11.15.3 Allogene Therapeutics(Pipeline) Product and Service Introduction
11.15.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.15.5 Recent Developments and Future Plans
11.16 Celyad(Pipeline)
11.16.1 Business Overview
11.16.2 CAR T-Cell Therapy Major Business
11.16.3 Celyad(Pipeline) Product and Service Introduction
11.16.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.16.5 Recent Developments and Future Plans
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.2.3 Legal Disclaimer